269 related articles for article (PubMed ID: 26247926)
1. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
Brooks N; Esparon S; Pouniotis D; Pietersz GA
Molecules; 2015 Aug; 20(8):14033-50. PubMed ID: 26247926
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.
Brooks N; Hsu J; Esparon S; Pouniotis D; Pietersz GA
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200528
[TBL] [Abstract][Full Text] [Related]
3. Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.
Pouniotis D; Tang CK; Apostolopoulos V; Pietersz G
Immunol Res; 2016 Aug; 64(4):887-900. PubMed ID: 27138940
[TBL] [Abstract][Full Text] [Related]
4. A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice.
Brooks NA; Pouniotis DS; Sheng KC; Apostolopoulos V; Pietersz GA
Biochim Biophys Acta; 2010 Dec; 1798(12):2286-95. PubMed ID: 20478265
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of the Tat cell-penetrating peptide into nanofibers improves the respective antitumor immune response.
Mohammadi M; Dehghani P; Mohseninia A; Roozbehani M; Hemphill A; Hesamizadeh K
J Cell Physiol; 2021 Feb; 236(2):1401-1417. PubMed ID: 32686113
[TBL] [Abstract][Full Text] [Related]
6. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
[TBL] [Abstract][Full Text] [Related]
7. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
[TBL] [Abstract][Full Text] [Related]
8. Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells.
Tanaka Y; Dowdy SF; Linehan DC; Eberlein TJ; Goedegebuure PS
J Immunol; 2003 Feb; 170(3):1291-8. PubMed ID: 12538688
[TBL] [Abstract][Full Text] [Related]
9. The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours.
Yang H; Cho NH; Seong SY
Clin Exp Immunol; 2009 Nov; 158(2):174-85. PubMed ID: 19737144
[TBL] [Abstract][Full Text] [Related]
10. Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.
Pouniotis DS; Apostolopoulos V; Pietersz GA
Immunology; 2006 Mar; 117(3):329-39. PubMed ID: 16476052
[TBL] [Abstract][Full Text] [Related]
11. Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model.
Kadkhodayan S; Jafarzade BS; Sadat SM; Motevalli F; Agi E; Bolhassani A
Immunol Lett; 2017 Aug; 188():38-45. PubMed ID: 28602843
[TBL] [Abstract][Full Text] [Related]
12. The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.
Gavioli R; Cellini S; Castaldello A; Voltan R; Gallerani E; Gagliardoni F; Fortini C; Cofano EB; Triulzi C; Cafaro A; Srivastava I; Barnett S; Caputo A; Ensoli B
Vaccine; 2008 Jan; 26(5):727-37. PubMed ID: 18096278
[TBL] [Abstract][Full Text] [Related]
13. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.
Apostolopoulos V; Pouniotis DS; van Maanen PJ; Andriessen RW; Lodding J; Xing PX; McKenzie IF; Loveland BE; Pietersz GA
Vaccine; 2006 Apr; 24(16):3191-202. PubMed ID: 16480791
[TBL] [Abstract][Full Text] [Related]
14. Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.
Buhl T; Braun A; Forkel S; Möbius W; van Werven L; Jahn O; Rezaei-Ghaleh N; Zweckstetter M; Mempel M; Schön MP; Haenssle HA
Exp Dermatol; 2014 Jan; 23(1):20-6. PubMed ID: 24372650
[TBL] [Abstract][Full Text] [Related]
15. Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.
Lei J; Osen W; Gardyan A; Hotz-Wagenblatt A; Wei G; Gissmann L; Eichmüller S; Löchelt M
PLoS One; 2015; 10(9):e0138458. PubMed ID: 26397953
[TBL] [Abstract][Full Text] [Related]
16. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
[TBL] [Abstract][Full Text] [Related]
17. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
[TBL] [Abstract][Full Text] [Related]
18. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the Antimicrobial Properties of Peptides through Cell-Penetrating Peptide Conjugation: A Comprehensive Assessment.
Kravchenko SV; Domnin PA; Grishin SY; Vershinin NA; Gurina EV; Zakharova AA; Azev VN; Mustaeva LG; Gorbunova EY; Kobyakova MI; Surin AK; Fadeev RS; Ostroumova OS; Ermolaeva SA; Galzitskaya OV
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069046
[TBL] [Abstract][Full Text] [Related]
20. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]